Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 110.31 0.57 (0.52%) Market Cap: 6.95 Bil Enterprise Value: 10.88 Bil PE Ratio: 22.74 PB Ratio: 1.88 GF Score: 78/100

Jazz Pharmaceuticals PLC at Jefferies London Healthcare Conference (Virtual) Transcript

Nov 16, 2021 / 04:20PM GMT
Release Date Price: $137.96 (-0.88%)
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

Well, good afternoon, everyone. I apologize, I was about to say good morning because I took a red eye from New York. I have the pleasure of hosting Jazz Pharmaceuticals. For those who don't know me, my name is Akash Tewari. I am a senior biotech analyst at Jefferies.

Joining us today from the Jazz team is Renee Gala, CFO; Dan Swisher, President; and then Samantha Pearce, who is Senior Vice President and Head of Europe and the international business for Jazz. I guess maybe before I get started with my own questions. maybe, Renee, if you want to take a few moments to introduce where Jazz is kind of as a company, and we'll take it from there. Go ahead.

Renee D. Gala
Jazz Pharmaceuticals plc - Executive VP & CFO

Sure. Great. I'd love to. Well, and also thank you for inviting us. We're thrilled to be here. Before we get started, though, I will remind you, we'll be making forward-looking statements today, so I would point you to our SEC filings on our website for more information on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot